Before a deadly heroin overdose at 27, Jean-Michel Basquiat finished an electrically vibrant skull, prompting questions today about arts donations generated by opioid profits.
AMA J Ethics. 2020;22(8):E735-738. doi:
10.1001/amajethics.2020.735.
Annette Hanson, MD, Ron Pies, MD, and Mark Komrad, MD
Authors respond to “How Should Physicians Care for Dying Patients with Amyotrophic Lateral Sclerosis?” by arguing that patients’ motives for accessing death with dignity laws should be thoroughly explored and that temporarily limiting patient autonomy can promote well-being at the end of life.
AMA J Ethics. 2018;20(11):E1107-1109. doi:
10.1001/amajethics.2018.1107.
Alexander Craig, MPhil and Elizabeth Dzeng, MD, PhD, MPH
Responding to “Added Points of Concern about Caring for Dying Patients,” authors argue that physicians’ refusal to prescribe lethal drugs in accordance with states’ death with dignity laws could damage patient-physician relationships and harm patients.
AMA J Ethics. 2018;20(11):E1110-1112. doi:
10.1001/amajethics.2018.1110.
Violence reduction efforts should be modeled on noncontagious diseases, which have as their root cause environmental determinants, not contagious diseases.
AMA J Ethics. 2018;20(5):513-515. doi:
10.1001/journalofethics.2018.20.5.corr1-1805.
Gary Slutkin, MD, Charles Ransford, MPP, and Daria Zvetina
Violence reduction efforts should focus on interrupting transmission of violence and changing behaviors rather than mitigating environmental risk factors.
AMA J Ethics. 2018;20(5):516-519. doi:
10.1001/journalofethics.2018.20.5.corr2-1805.
Kristen N. Pallok and David A. Ansell’s “Should Clinicians Be Activists?” highlights how physician activists risk retaliation from “economically and socially” privileged physician leaders and organizational leadership who “have been trained to comply” with structural inequity.
AMA J Ethics. 2022;24(7):E694-696. doi:
10.1001/amajethics.2022.694.